Status:
COMPLETED
Effect of Curcumin on Microvascular Response and Tissue Oxygenation
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
Aging has been associated with reduced bioavailability of nitric oxide(NO) and endotelial dysfunction.Curcumin, a phenolic compound present in the rhizomes of turmeric, possesses cardiovascular protec...
Detailed Description
Aging has been associated with reduced bioavailability of nitric oxide(NO) and endotelial dysfunction. Curcumin, a phenolic compound present in the rhizomes of turmeric, possesses cardiovascular prot...
Eligibility Criteria
Inclusion
- Seniors,
- With two or more risk factors for cardiovascular disease:Dyslipidemia, visceral obesity, hypertension, diabetes mellitus 2 and others.
Exclusion
- Smoking,
- Use of antioxidant drugs during the experiment period,
- Allergy to components of curcumin,
- With previous history of cancer, HIV,
- Neurodegenerative and osteomioarticular diseases.
Key Trial Info
Start Date :
January 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 24 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04119752
Start Date
January 4 2019
End Date
June 24 2020
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Coexistence of the Elderly
Macaé, Rio de Janeiro, Brazil